Insulin Syringes Voluntarily Recalled

Accusure insulin syringes (Qualitest Pharmaceuticals, Inc.) distributed nationwide from January 2007through June 2008 are undergoing voluntary recall because of the detachment of needles from the syringes. 

The syringes in question include the 31 G-Short Needle — either 0.5 cc or 1 cc, lot number 6JCB1 or lot number 7CPT1. Lot numbers are found on the white paper backing of each individual syringe, according to the US Food and Drug Administration (FDA) report. 

“When the needle becomes detached from the syringe during use, it can become stuck in the insulin vial, push back into the syringe, or remain in the skin after an injection,” according to the statement from MedWatch, the FDA’s safety information and adverse event reporting program. 

Patients should stop using the syringe and contact Qualitest at 1-800-444-4011 for product replacement instructions. 

Adverse events related to use of Accusure Insulin Syringes should be communicated to the FDA’s MedWatch reporting program by telephone at 1-800-FDA-1088, by fax at 1-800-FDA-0178, online at https://www.fda.gov/medwatch, or by mail to 5600 Fishers Lane, Rockville, Maryland, USA, 20852-9787.